CHA Bundang Medical Center, CHA University — Seongnam-si, Gyeonggi-do

Public research footprint of CHA Bundang Medical Center, CHA University, compiled from the ClinicalTrials.gov public registry.

104

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · Gastric Cancer · Breast Cancer

Recently updated registry entries

NCT06016842 — A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (Recruiting)
NCT03466411 — A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to… (Active Not Recruiting)
NCT05388669 — A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHA Bundang Medical Center, CHA University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.